Identifying and managing deprivation of liberty in adults in England and Wales
Abstract
Clinicians are required by law to be able to identify and manage deprivation of liberty—this article explains how to do so
Clinicians are required by law to be able to identify and manage deprivation of liberty—this article explains how to do so
T. Nicholson, W. Cutter, M. Hotopf (2008)
Assessing mental capacity: the Mental Capacity ActBMJ : British Medical Journal, 336
F. Oyebode (2006)
The Mental Capacity Act 2005.Clinical medicine, 6 2
Satoru Yatsuji, E. Hashimoto (2006)
[Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC)].Nihon rinsho. Japanese journal of clinical medicine, 64 6
R. Vuppalanchi, N. Chalasani (2009)
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementHepatology, 49
A. Perra, G. Simbula, M. Simbula, M. Pibiri, M. Kowalik, P. Sulas, M. Cocco, G. Ledda-Columbano, A. Columbano (2008)
Thyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in ratsThe FASEB Journal, 22
A. Chidakel, D. Mentuccia, F. Celi (2005)
Peripheral metabolism of thyroid hormone and glucose homeostasis.Thyroid : official journal of the American Thyroid Association, 15 8
Alan Erickson, RAYMOND Enzenauer, David Nordstrom, John Merenich (1994)
The prevalence of hypothyroidism in gout.The American journal of medicine, 97 3
S. Liangpunsakul, N. Chalasani (2003)
Is Hypothyroidism a Risk Factor for Non-Alcoholic Steatohepatitis?Journal of Clinical Gastroenterology, 37
J. Browning, L. Szczepaniak, R. Dobbins, Pamela Nuremberg, J. Horton, Jonathan Cohen, S. Grundy, H. Hobbs (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicityHepatology, 40
K. Hashimoto, R. Cohen, M. Yamada, Kathleen Markan, T. Monden, T. Satoh, M. Mori, F. Wondisford (2006)
Cross-talk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model*Journal of Biological Chemistry, 281
N. Bhala, T. Usherwood, J. George (2009)
Non-alcoholic fatty liver diseaseBMJ : British Medical Journal, 339
Elizabeth Thomas, G. Hamilton, N. Patel, R. O'Dwyer, C. Doré, R. Goldin, Jimmy Bell, S. Taylor-Robinson (2004)
Oesophageal ulceration: more than meets the naked eye?Gut, 54
E. Cable, P. Finn, J. Stebbins, J. Hou, B. Ito, P. Poelje, D. Linemeyer, M. Erion (2009)
Reduction of hepatic steatosis in rats and mice after treatment with a liver‐targeted thyroid hormone receptor agonistHepatology, 49
A. Lonardo, P. Loria, F. Leonardi, D. Ganazzi, N. Carulli (2002)
Growth hormone plasma levels in nonalcoholic fatty liver diseaseAmerican Journal of Gastroenterology, 97
R. Jones (1988)
Mental Health Act Manual
J. Hamilton (1983)
Mental Health Act 1983.British Medical Journal (Clinical research ed.), 286
Manal Hassan, A. Kaseb, Donghui Li, Y. Patt, J. Vauthey, M. Thomas, S. Curley, M. Spitz, S. Sherman, E. Abdalla, M. Davila, R. Lozano, Deena Hassan, W. Chan, T. Brown, J. Abbruzzese (2009)
Association between hypothyroidism and hepatocellular carcinoma: A case‐control study in the United StatesHepatology, 49
M. Erion, E. Cable, B. Ito, Hongjian Jiang, J. Fujitaki, P. Finn, Bao-Hong Zhang, J. Hou, S. Boyer, P. Poelje, D. Linemeyer (2007)
Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic indexProceedings of the National Academy of Sciences, 104
P. Loria, L. Carulli, M. Bertolotti, A. Lonardo (2009)
Endocrine and liver interaction: the role of endocrine pathways in NASHNature Reviews Gastroenterology &Hepatology, 6
G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A. McCullough, S. Natale, G. Forlani, N. Melchionda (2001)
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.Diabetes, 50 8
A. Zigmond (2009)
Deprivation of liberty safeguards and the Mental Capacity ActBMJ : British Medical Journal, 338
E. Nyenwe, Sarah Williamson-Baddorf, B. Waters, J. Wan, S. Solomon (2009)
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome in Hypopituitary PatientsThe American Journal of the Medical Sciences, 338
J. Ludwig, T. Viggiano, D. McGill, B. Oh (1980)
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.Mayo Clinic proceedings, 55 7
Clinicians are required by law to be able to identify and manage deprivation of liberty—this article explains how to do so
BMJ – British Medical Journal
Published: Jan 10, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.